Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Theresa L. Whiteside. (2019) Human regulatory T cells (Treg) and their response to cancer. Expert Review of Precision Medicine and Drug Development 4:4, pages 215-228.
Read now
Read now
Theresa L. Whiteside. (2018) FOXP3+ Treg as a therapeutic target for promoting anti-tumor immunity. Expert Opinion on Therapeutic Targets 22:4, pages 353-363.
Read now
Read now
Theresa L Whiteside. (2017) Targeting adenosine in cancer immunotherapy: a review of recent progress. Expert Review of Anticancer Therapy 17:6, pages 527-535.
Read now
Read now
Theresa L Whiteside. (2015) The role of regulatory T cells in cancer immunology. ImmunoTargets and Therapy 4, pages 159-171.
Read now
Read now
Theresa L Whiteside. (2014) Induced regulatory T cells in inhibitory microenvironments created by cancer. Expert Opinion on Biological Therapy 14:10, pages 1411-1425.
Read now
Read now
Sylvia Muller-Haegele, Laurent Muller & Theresa L Whiteside. (2014) Immunoregulatory activity of adenosine and its role in human cancer progression. Expert Review of Clinical Immunology 10:7, pages 897-914.
Read now
Read now
Belal Chaudhary, May Abd Al Samid, Basel K al-Ramadi & Eyad Elkord. (2014) Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer. Expert Opinion on Biological Therapy 14:7, pages 931-945.
Read now
Read now
Laurence Zitvogel, Corinne Tanchot, Clemence Granier & Eric Tartour. (2013) Following up tumor-specific regulatory T cells in cancer patients. OncoImmunology 2:7.
Read now
Read now
Articles from other publishers (43)
Jiayu Li, Shuhan Ma, Hongdi Pei, Jici Jiang, Quan Zou & Zhibin Lv. (2023) Review of T cell proliferation regulatory factors in treatment and prognostic prediction for solid tumors. Heliyon 9:11, pages e21329.
Crossref
Crossref
Domenico Galati, Serena Zanotta, Mariaelena Capone, Gabriele Madonna, Domenico Mallardo, Marilena Romanelli, Ester Simeone, Lucia Festino, Francesca Sparano, Rosa Azzaro, Rosaria De Filippi, Antonio Pinto, Chrystal M. Paulos & Paolo A. Ascierto. (2023) Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients. Journal of Translational Medicine 21:1.
Crossref
Crossref
Hao Chi, Jinyan Yang, Gaoge Peng, Jinhao Zhang, Guobin Song, Xixi Xie, Zhijia Xia, Jinhui Liu & Gang Tian. (2023) Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity. Frontiers in Immunology 14.
Crossref
Crossref
Martina Chirra, Hannah S. Newton, Vaibhavkumar S. Gawali, Trisha M. Wise-Draper, Ameet A. Chimote & Laura Conforti. (2022) How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor Immunity. Cancers 14:15, pages 3564.
Crossref
Crossref
Sophia Schulte, Janna Heide, Christin Ackermann, Sven Peine, Michael Ramharter, Maria Sophia Mackroth, Robin Woost, Thomas Jacobs & Julian Schulze zur Wiesch. (2022)
Deciphering the
Plasmodium falciparum
malaria-specific CD4+ T-cell response:
ex vivo
detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramer
. Clinical and Experimental Immunology 207:2, pages 227-236.
Crossref
Crossref
Galina Zhulai, Eugenia Oleinik, Mikhail Shibaev & Kirill Ignatev. (2022) Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer. Biomolecules 12:3, pages 418.
Crossref
Crossref
Georgina I. López-Cortés, Laura Díaz-Alvarez & Enrique Ortega. (2021) Leukocyte Membrane Enzymes Play the Cell Adhesion Game. Frontiers in Immunology 12.
Crossref
Crossref
Oscar J. Cordero, Carlos Rafael-Vidal, Rubén Varela-Calviño, Cristina Calviño-Sampedro, Beatriz Malvar-Fernández, Samuel García, Juan E. Viñuela & José M. Pego-Reigosa. (2021) Distinctive CD26 Expression on CD4 T-Cell Subsets. Biomolecules 11:10, pages 1446.
Crossref
Crossref
Hannah S. Newton, Ameet A. Chimote, Michael J. Arnold, Trisha M. Wise-Draper & Laura Conforti. (2021) Targeted knockdown of the adenosine A2A receptor by lipid NPs rescues the chemotaxis of head and neck cancer memory T cells. Molecular Therapy - Methods & Clinical Development 21, pages 133-143.
Crossref
Crossref
Achim K. Moesta, Xian-Yang Li & Mark J. Smyth. (2020) Targeting CD39 in cancer. Nature Reviews Immunology 20:12, pages 739-755.
Crossref
Crossref
Hannah S Newton, Vaibhavkumar S Gawali, Ameet A Chimote, Maria A Lehn, Sarah M Palackdharry, Benjamin H Hinrichs, Roman Jandarov, David Hildeman, Edith M Janssen, Trisha M Wise-Draper & Laura Conforti. (2020)
PD1 blockade enhances K
+
channel activity, Ca
2+
signaling, and migratory ability in cytotoxic T lymphocytes of patients with head and neck cancer
. Journal for ImmunoTherapy of Cancer 8:2, pages e000844.
Crossref
Crossref
Sebastián Alarcón, María de los Ángeles Toro, Carolina Villarreal, Rómulo Melo, Rodrigo Fernández, Angel Ayuso Sacido, Daniel Uribe, Rody San Martín & Claudia Quezada. (2020) Decreased Equilibrative Nucleoside Transporter 1 (ENT1) Activity Contributes to the High Extracellular Adenosine Levels in Mesenchymal Glioblastoma Stem-Like Cells. Cells 9:8, pages 1914.
Crossref
Crossref
Parham Jabbarzadeh Kaboli, Lingling Zhang, Shixin Xiang, Jing Shen, Mingxing Li, Yueshui Zhao, Xu Wu, Qijie Zhao, Hanyu Zhang, Ling Lin, Jianhua Yin, Yuanlin Wu, Lin Wan, Tao Yi, Xiang Li, Chi Hin Cho, Jing Li, Zhangang Xiao & Qinglian Wen. (2020) Molecular Markers of Regulatory T Cells in Cancer Immunotherapy with Special Focus on Acute Myeloid Leukemia (AML) - A Systematic Review. Current Medicinal Chemistry 27:28, pages 4673-4698.
Crossref
Crossref
Ameet A. Chimote, Vaibhavkumar S. Gawali, Hannah S. Newton, Trisha M. Wise-Draper & Laura Conforti. (2020) A Compartmentalized Reduction in Membrane-Proximal Calmodulin Reduces the Immune Surveillance Capabilities of CD8+ T Cells in Head and Neck Cancer. Frontiers in Pharmacology 11.
Crossref
Crossref
David Allard, Bertrand Allard & John Stagg. (2020) On the mechanism of anti-CD39 immune checkpoint therapy. Journal for ImmunoTherapy of Cancer 8:1, pages e000186.
Crossref
Crossref
N. Ludwig & M. T. Lotze. (2020) A treatise on endothelial biology and exosomes: homage to Theresa Maria Listowska WhitesideEndothelbiologie und Exosomen – eine Hommage auf Theresa Maria Listowska Whiteside. HNO 68:2, pages 71-79.
Crossref
Crossref
Jean L.G. da Silva, Daniela F. Passos, Viviane M. Bernardes & Daniela B.R. Leal. (2019) ATP and adenosine: Role in the immunopathogenesis of rheumatoid arthritis. Immunology Letters 214, pages 55-64.
Crossref
Crossref
Juan José Nieto-Fontarigo, Francisco Javier Salgado, María Esther San-José, María Jesús Cruz, Luis Valdés, Amparo Pérez-Díaz, Pilar Arias, Montserrat Nogueira & Francisco Javier González-Barcala. (2019) Expansion of different subpopulations of CD26−/low T cells in allergic and non-allergic asthmatics. Scientific Reports 9:1.
Crossref
Crossref
Reza Khayami, Younes Toroghian, Amirhossein Bahreyni, Afsane Bahrami, Majid Khazaei, Gordon A. Ferns, Safieh Ebrahimi, Anvar Soleimani, Hamid Fiuji, Amir Avan & Seyed Mahdi Hassanian. (2018) Role of adenosine signaling in the pathogenesis of head and neck cancer. Journal of Cellular Biochemistry 119:10, pages 7905-7912.
Crossref
Crossref
M-N Theodoraki, T K Hoffmann, E K Jackson & T L Whiteside. (2018) Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence. Clinical and Experimental Immunology 194:1, pages 67-78.
Crossref
Crossref
Markus D. Lacher, Gerhard Bauer, Brian Fury, Sanne Graeve, Emily L. Fledderman, Tye D. Petrie, Dane P. Coleal-Bergum, Tia Hackett, Nicholas H. Perotti, Ying Y. Kong, William W. Kwok, Joseph P. Wagner, Charles L. Wiseman & William V. Williams. (2018) SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes. Frontiers in Immunology 9.
Crossref
Crossref
Ameet A. Chimote, Andras Balajthy, Michael J. ArnoldHannah S. NewtonPeter HajduJulianne QualtieriTrisha Wise-Draper & Laura Conforti. (2018)
A defect in KCa3.1 channel activity limits the ability of CD8
+
T cells from cancer patients to infiltrate an adenosine-rich microenvironment
. Science Signaling 11:527.
Crossref
Crossref
Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro & Maria Luisa Trabachin. (2018) Dipeptidyl peptidase-4 inhibitors (DPP-4i) combined with vitamin D3: An exploration to treat new-onset type 1 diabetes mellitus and latent autoimmune diabetes in adults in the future. International Immunopharmacology 57, pages 11-17.
Crossref
Crossref
Estefanía Moreno, Júlia Canet, Eduard Gracia, Carme Lluís, Josefa Mallol, Enric I. Canela, Antoni Cortés & Vicent Casadó. (2018) Molecular Evidence of Adenosine Deaminase Linking Adenosine A2A Receptor and CD26 Proteins. Frontiers in Pharmacology 9.
Crossref
Crossref
Lovis Kling, Urs Benck, Annette Breedijk, Lisa Leikeim, Marianne Heitzmann, Stefan Porubsky, Bernhard K. Krämer, Benito A. Yard & Anna-Isabelle Kälsch. (2017) Changes in CD73, CD39 and CD26 expression on T-lymphocytes of ANCA-associated vasculitis patients suggest impairment in adenosine generation and turn-over. Scientific Reports 7:1.
Crossref
Crossref
Bertrand Allard, Maria Serena Longhi, Simon C. Robson & John Stagg. (2017) The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets. Immunological Reviews 276:1, pages 121-144.
Crossref
Crossref
Yuliia Kaljas, Chengqian Liu, Maksym Skaldin, Chengxiang Wu, Qing Zhou, Yuanan Lu, Ivona Aksentijevich & Andrey V. Zavialov. (2016) Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells. Cellular and Molecular Life Sciences 74:3, pages 555-570.
Crossref
Crossref
Jianda Yuan, Priti S. Hegde, Raphael Clynes, Periklis G. Foukas, Alexandre Harari, Thomas O. Kleen, Pia Kvistborg, Cristina Maccalli, Holden T. Maecker, David B. Page, Harlan Robins, Wenru Song, Edward C. Stack, Ena Wang, Theresa L. Whiteside, Yingdong Zhao, Heinz Zwierzina, Lisa H. Butterfield & Bernard A. Fox. (2016) Novel technologies and emerging biomarkers for personalized cancer immunotherapy. Journal for ImmunoTherapy of Cancer 4:1.
Crossref
Crossref
Cesar Sepúlveda, Iván Palomo & Eduardo Fuentes. (2016) Role of adenosine A2b receptor overexpression in tumor progression. Life Sciences 166, pages 92-99.
Crossref
Crossref
M. Mandapathil. (2016) Adenosine-mediated immunosuppression in patients with squamous cell carcinoma of the head and neckAdenosinvermittelte Immunsuppression bei Patienten mit Kopf-Hals-Plattenepithelkarzinomen. HNO 64:5, pages 303-309.
Crossref
Crossref
Patrik Sundström, Hanna Stenstad, Veronica Langenes, Filip Ahlmanner, Lisa Theander, Tapuka Gordon Ndah, Kamilla Fredin, Lars Börjesson, Bengt Gustavsson, Jérémy Bastid & Marianne Quiding-Järbrink. (2016) Regulatory T Cells from Colon Cancer Patients Inhibit Effector T-cell Migration through an Adenosine-Dependent Mechanism. Cancer Immunology Research 4:3, pages 183-193.
Crossref
Crossref
Theresa L. Whiteside. (2014) Clinical Impact of Regulatory T cells (Treg) in Cancer and HIV. Cancer Microenvironment 8:3, pages 201-207.
Crossref
Crossref
Jing Hua, Scott P. Davis, Jonathan A. Hill & Tetsuya Yamagata. (2015) Diverse Gene Expression in Human Regulatory T Cell Subsets Uncovers Connection between Regulatory T Cell Genes and Suppressive Function. The Journal of Immunology 195:8, pages 3642-3653.
Crossref
Crossref
Jeremy Bastid, Anne Regairaz, Nathalie Bonnefoy, Cécile Déjou, Jérôme Giustiniani, Caroline Laheurte, Stéphanie Cochaud, Emilie Laprevotte, Elisa Funck-Brentano, Patrice Hemon, Laurent Gros, Nicole Bec, Christian Larroque, Gilles Alberici, Armand Bensussan & Jean-François Eliaou. (2015) Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity. Cancer Immunology Research 3:3, pages 254-265.
Crossref
Crossref
Antoni Cortés, Eduard Gracia, Estefania Moreno, Josefa Mallol, Carme Lluís, Enric I. Canela & Vicent Casadó. (2015) Moonlighting Adenosine Deaminase: A Target Protein for Drug Development. Medicinal Research Reviews 35:1, pages 85-125.
Crossref
Crossref
Olivier Morales, Dhafer Mrizak, Violaine François, Rami Mustapha, Céline Miroux, Stéphane Depil, Anne-Valérie Decouvelaere, Pauline Lionne-Huyghe, Claude Auriault, Yvan de Launoit, Véronique Pancré & Nadira Delhem. (2014) Epstein-Barr virus infection induces an increase of T regulatory type 1 cells in Hodgkin lymphoma patients. British Journal of Haematology 166:6, pages 875-890.
Crossref
Crossref
Rosa Di Gaetano, Valentina Gasparetto, Andrea Padoan, Barbara Callegari, Laura Candiotto, Maria Colomba Sanzari, Antonio Scapinello & Giuseppe Tagariello. (2014) Flow cytometry CD4+CD26−CD38+ lymphocyte subset in the microenvironment of Hodgkin lymphoma-affected lymph nodes. Annals of Hematology 93:8, pages 1319-1326.
Crossref
Crossref
P J Schuler, Z Saze, C-S Hong, L Muller, D G Gillespie, D Cheng, M Harasymczuk, M Mandapathil, S Lang, E K Jackson & T L Whiteside. (2014) Human CD4+CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells. Clinical and Experimental Immunology 177:2, pages 531-543.
Crossref
Crossref
Yunjie Lu, Jirong Wang, Jian Gu, Hao Lu, Xiangcheng Li, Xiaofeng Qian, Xiaoshan Liu, Xuehao Wang, Feng Zhang & Ling Lu. (2014) Rapamycin Regulates iTreg Function through CD39 and Runx1 Pathways. Journal of Immunology Research 2014, pages 1-8.
Crossref
Crossref
Ameet A. Chimote, Peter Hajdu, Vladimir Kucher, Nina Boiko, Zerrin Kuras, Orsolya Szilagyi, Yeo-Heung Yun & Laura Conforti. (2013) Selective Inhibition of KCa3.1 Channels Mediates Adenosine Regulation of the Motility of Human T Cells. The Journal of Immunology 191:12, pages 6273-6280.
Crossref
Crossref
C. Tanchot, M. Terme, H. Pere, T. Tran, N. Benhamouda, M. Strioga, C. Banissi, L. Galluzzi, G. Kroemer & E. Tartour. (2012) Tumor-Infiltrating Regulatory T Cells: Phenotype, Role, Mechanism of Expansion In Situ and Clinical Significance. Cancer Microenvironment 6:2, pages 147-157.
Crossref
Crossref
Jennifer P. Chou, Christina M. Ramirez, Jennifer E. Wu & Rita B. Effros. (2013) Accelerated Aging in HIV/AIDS: Novel Biomarkers of Senescent Human CD8+ T Cells. PLoS ONE 8:5, pages e64702.
Crossref
Crossref
Shu Bian, Xiaofeng Sun, Aiping Bai, Chunqing Zhang, Linglin Li, Keiichi Enjyoji, Wolfgang G. Junger, Simon C. Robson & Yan Wu. (2013) P2X7 Integrates PI3K/AKT and AMPK-PRAS40-mTOR Signaling Pathways to Mediate Tumor Cell Death. PLoS ONE 8:4, pages e60184.
Crossref
Crossref